Nigeria vs Uganda: HIV/AIDS deaths averted by antiretroviral therapy
Nigeria
107,142 deaths
in 2024
Uganda
82,921 deaths
in 2024
Nigeria rank
3rd
Uganda rank
6th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Nigeria
- Uganda
How they compare
Nigeria currently reports 107,142 deaths against 82,921 deaths in Uganda, a difference of 24,221 deaths.
That makes Nigeria's figure about 1.3 times Uganda's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Uganda ahead.
Nigeria ranks 3rd and Uganda ranks 6th of 157 countries.
Nigeria has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Nigeria | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 16,764 deaths | 12,859 deaths | 3,905 deaths | Nigeria |
| 2010s | 74,507 deaths | 56,072 deaths | 18,435 deaths | Nigeria |
| 2020s | 101,103 deaths | 81,329 deaths | 19,774 deaths | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Nigeria or Uganda?
- Nigeria, at 107,142 deaths against 82,921 deaths in Uganda as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Nigeria and Uganda?
- 24,221 deaths, with Nigeria ahead.
- How many years of comparable data are there for Nigeria and Uganda?
- 35 years are reported by both, from 1990 to 2024.
- How do Nigeria and Uganda rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Nigeria ranks 3rd and Uganda ranks 6th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.